Abstract: A needle device has a needle assembly including a hub having one end fitted with a blunt cannula. The blunt cannula has a base section, a central section and a shaft having a distal apertured end. The needle of the needle assembly extends through an internal passage of the blunt cannula and is sealingly fitted to a portion of the internal passage. The hub of the needle assembly has another end connectable to a syringe. When the device is connected to a syringe, a fluid communication path is established between the apertured end of the shaft and the interior of the syringe via the lumen of the needle. The shaft of the blunt cannula is usable to pierce the seal of a fluid store while maintaining the needle in an unused state for subsequent patient use. The distal end of the shaft may be protected by an end cap.

Abstract: A catheter assembly includes a catheter hub defining an interior cavity and a catheter tube extending distally thereof. A rigid actuator extends proximally in the interior cavity and supports a seal member thereon. The seal member includes a central membrane, a distal portion, and a proximal portion. An hourglass shaped actuator cavity is formed in the distal portion and receives a barbed end of the actuator. The outer surface of the seal member is in partial circumferential engagement with the catheter hub to define an air path that allows fluid communication between areas of the interior cavity distal and proximal of the seal member. A punch tool is provided to form a tri-slit in the membrane of the seal member.

Abstract: An infusion pump includes a pumping mechanism having at least one sensor and a pump motor and a pump control subsystem configured to control operation of the pumping mechanism, the pump control subsystem including a processor, a memory, and a startup module configured to drive the pump motor at a first rate, receive input from the at least one sensor, and drive the pump motor at a second rate based on the input received from the at least one sensor. Startup algorithms command an infusion pump to reach a targeted delivery rate or steady state in minimal time without requiring priming of the pump line or otherwise engaging in known methods of pump startup analysis.

Abstract: An embodiment of a medication dispenser comprises a drug pump having a control module. A medication dose request device can be in communication with the drug pump. A dispensing device, for dispensing substantially solid medication in response to activation of the medication dose request device, can be in communication with the drug pump.

Abstract: Embodiments relate generally to drug delivery infusion profiles that can be transferred and executed on infusion pumps without the need for loading new firmware. Particularly, embodiments relate to integrating and/or editing delivery profiles for execution infusion systems. Such systems can include target-controlled infusion systems. Advantages of such embodiments include enabling healthcare providers and medical device companies to respond quickly to changes in infusion pump technology, drug development, and pharmacokinetics by providing the ability to create, edit, integrate, and store delivery profiles to accommodate these changes.

Abstract: A receiving box receives items for later retrieval by an enterprise. Upon an amount of received items being detected within the receiving box, a report is sent to the enterprise. A detector detects an amount of the received items in the receiving box and outputs a corresponding signal. A controller receives the signal and determines based thereon whether a triggering event has occurred. The triggering event represents that the receiving box has an amount of received items therein such that a person or service should be dispatched from the enterprise to the receiving box to empty same. A reporter is employed by the controller to report the triggering event as a message to the enterprise upon the controller determining that the triggering event has occurred.

Abstract: An apparatus, method and program product detects an occlusion in a fluid line by determining if a relationship between force measurements departs from an expected relationship.

Abstract: Methods and systems of patient treatment are disclosed. The methods and systems include use of medical device informatics to modify and validate therapies and drugs used in those therapies. In certain embodiments, a medical device, such as a medical infusion pump, interfaces with a server to administer the patient treatments. In one aspect, a method of tracking changed parameters in a medical infusion pump is disclosed. The method includes establishing a communication session between a medical infusion pump and a medical device server, and communicating an original parameter value, an updated parameter value, and a final parameter value from the medical infusion pump to the medical device server. The method further includes storing the original parameter value, the updated parameter value, and the final parameter value on the medical device server. Metadata associated with one or more of the parameter values identifies that parameter value to the medical device server and the medical infusion pump.

Abstract: The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.

Abstract: A catheter assembly includes a catheter hub defining an interior cavity and a catheter tube extending distally thereof. A rigid actuator is positioned to extend proximally in the interior cavity and support a seal member positioned thereon in the interior cavity. The seal member includes a central membrane, a distal portion, and a proximal portion. An hourglass shaped actuator cavity is formed in the distal portion and receives a barbed end of the actuator. The outer surface of the seal member is in partial circumferential engagement with the catheter hub to define an air path that allows fluid communication between areas of the interior cavity distal and proximal of the seal member. The seal member may be configured for multi-use and include a biasing member that moves the seal member to force the membrane back over the actuator to close the membrane.

Abstract: An apparatus, method and program product detects an occlusion in a fluid line by determining if a relationship between force measurements departs from an expected relationship.

Abstract: Embodiments include an infusion pump providing safe and reliable touchless control. The infusion pump includes a pump housing, a pumping mechanism coupled to the pump housing that selectively delivers medicament to a patient, a pump control system including a processor and a memory programmable to control operation of the pumping mechanism, and a touchless control module for relaying commands to the pump control system. The touchless control module includes a first touchless user interface configured to receive a touchless programming command for the infusion pump from a user and a second touchless user interface configured to confirm the touchless programming command by receipt of a touchless confirmation command from the user.

Abstract: An application instantiated on a computing device of a professional receives transmitted information on an incoming call from a client and displays same, including an identifier of the client by which the professional can place a return call thereto. Upon the professional selecting the identifier of the client, the application presents a number of options for an identifier of the professional to be provided with the return call, receives a selection of one of the options, places the return call from the professional to the client, and in doing so provides the selected identifier of the professional. The provided identifier of the professional represents a favored location at which the professional or an associate may be reached. The client may ascertain the provided identifier from the return call and employ same to place a future call toward the professional or the associate.

Abstract: A catheter assembly includes a catheter hub defining an interior cavity and a catheter tube extending distally thereof. A rigid actuator is positioned to extend proximally in the interior cavity and support a seal member positioned thereon in the interior cavity. The seal member includes a central membrane, a distal portion, and a proximal portion. An hourglass shaped actuator cavity is formed in the distal portion and receives a barbed end of the actuator. The outer surface of the seal member is in partial circumferential engagement with the catheter hub to define an air path that allows fluid communication between areas of the interior cavity distal and proximal of the seal member. The seal member may be configured for multi-use and include a biasing member that moves the seal member to force the membrane back over the actuator to close the membrane.

Abstract: A combination underbody and overbody blanket has first and second portions sandwiching a middle portion. The first portion may be shorter than the second portion. At least one air inlet is provided at the middle portion to allow air to be input into the blanket. The blanket is configured in the shape of a poncho, with the first portion covering the front torso of the patient and the second portion covering the back of the patient. A tearable seal is provided at the first portion that allows the first portion to be separated into two halves to expose the front upper torso of the patient and/or to facilitate the placement of the middle portion about the neck and onto the shoulders of the patient.

Abstract: An implantable portal includes a septum that has embedded therein a plurality of formations that together form an indicia adapted to identify at least one characteristic of the portal. The formations are configured from impressions formed on different layers of the septum spatially separated along the vertical axis of the septum. The impressions are filled with a radiopaque material. The superposed formations do not overlap when viewed from atop the septum. When viewed under radiographic imaging from the top of the septum, a 3-D identification indicia is presented to the viewer. The 3-D indicia may be used as a 3-D marker to focus the location of the septum where a needle to access the fluid reservoir of the portal may be inserted.

Abstract: A pump has a housing having at least one inlet, one outlet, and an internal track with a given configuration. A piston movably positioned inside the housing has at least one protuberance movably mated to the track. As the piston is reciprocally driven by a motor, it is guided by the movement of the protuberance along the track to move bidirectionally along the housing and selectively rotate such that when the piston is moved to a first position, a fluid path is established through the inlet to enable fluid to be input into the housing. When the piston is moved to a second position, another fluid path is established through the outlet so that fluid is output from the housing. Multiple chambers may be formed in the housing to enable synchronous and selective opening and closing of respective inlets and outlets to enhance fluid flow.

Abstract: This document discusses, among other things, an apparatus comprising a pump configured to deliver insulin, a processor, and a user interface including a bistable display. A display element of the bistable display is placed in one of two stable orientations upon application of a biasing voltage and stays in the stable orientation when the biasing voltage is removed. The processor includes a display module configured to display a non-blank reversion display screen on the bistable display when no input is received at the user interface after a specified time duration, and to recurrently change the reversion display screen until input is received at the user interface.

Abstract: The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.

Abstract: A clam shell shaped adapter for connecting a fluid output device and a fluid input device to establish a fluid path between the fluid output and input devices has first and second shells integrally connected by a living hinge. The first shell has a connector fitting end and a catheter end connected by a tubing. The fluid output device may be a catheter that is matable to the catheter end. A retainer structure in the adapter fixedly retains the catheter when the first and second shells close upon each other. Respective latch mechanisms provided at the first and second shells lockingly couple the first and second shells to each other. The fitting end has a given configuration that prevents the fitting end from mating with a counterpart conventional luer fitting but enables the fitting end to mate with a counterpart connector fitting that has a special configuration that mirrors the given configuration.